IAMGOLD (NYSE:IAG – Get Free Report) (TSE:IMG) is scheduled to issue its quarterly earnings data after the market closes on Thursday, November 7th. Analysts expect the company to announce earnings of $0.11 per share for the quarter. Persons that are interested in participating in the company’s earnings conference call can do so using this link.
IAMGOLD (NYSE:IAG – Get Free Report) (TSE:IMG) last issued its quarterly earnings data on Thursday, August 8th. The mining company reported $0.16 earnings per share for the quarter, beating the consensus estimate of $0.08 by $0.08. IAMGOLD had a net margin of 10.36% and a return on equity of 6.70%. The firm had revenue of $385.30 million for the quarter. During the same quarter in the prior year, the business earned ($0.01) earnings per share. On average, analysts expect IAMGOLD to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.
IAMGOLD Price Performance
Shares of NYSE:IAG opened at $5.29 on Tuesday. The firm’s 50 day moving average is $5.25 and its two-hundred day moving average is $4.47. The firm has a market capitalization of $3.02 billion, a P/E ratio of 21.16 and a beta of 1.57. The company has a current ratio of 1.34, a quick ratio of 0.90 and a debt-to-equity ratio of 0.30. IAMGOLD has a 52 week low of $2.11 and a 52 week high of $6.37.
Analyst Ratings Changes
View Our Latest Report on IAMGOLD
IAMGOLD Company Profile
IAMGOLD Corporation, through its subsidiaries, operates as an intermediate gold producer and developer in Canada and Burkina Faso. It owns 100% interest in the Westwood project that covers an area of 1,925 hectare and located in Quebec; a 60% interest in the Côté gold project, which covers an area of 596 square kilometer located in Ontario, Canada; and a 90% interests in the Essakane project that covers an area of 274,000 square kilometer situated in Burkina Faso.
Further Reading
- Five stocks we like better than IAMGOLD
- Are Penny Stocks a Good Fit for Your Portfolio?
- Intel: Is Now the Time to Be Brave?
- Manufacturing Stocks Investing
- Carnival or Royal Caribbean—Which Cruise Stock Has More Upside?
- How to Most Effectively Use the MarketBeat Earnings Screener
- Summit Therapeutics: Is Their Lung Cancer Drug a Game Changer?
Receive News & Ratings for IAMGOLD Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IAMGOLD and related companies with MarketBeat.com's FREE daily email newsletter.